156 related articles for article (PubMed ID: 10828886)
1. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures.
Mattot V; Vercamer C; Soncin F; Calmels T; Huguet C; Fafeur V; Vandenbunder B
Oncogene; 2000 Feb; 19(6):762-72. PubMed ID: 10698494
[TBL] [Abstract][Full Text] [Related]
3. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.
Le Bras A; Lionneton F; Mattot V; Lelièvre E; Caetano B; Spruyt N; Soncin F
Oncogene; 2007 Nov; 26(53):7480-9. PubMed ID: 17563748
[TBL] [Abstract][Full Text] [Related]
4. [Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis].
Lelièvre E; Lionneton F; Soncin F
Bull Cancer; 2001 Feb; 88(2):137-42. PubMed ID: 11257588
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
7. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
8. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
9. Role of ETS1 in IL-2 gene expression.
Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
[TBL] [Abstract][Full Text] [Related]
11. SP100 inhibits ETS1 activity in primary endothelial cells.
Yordy JS; Moussa O; Pei H; Chaussabel D; Li R; Watson DK
Oncogene; 2005 Jan; 24(5):916-31. PubMed ID: 15592518
[TBL] [Abstract][Full Text] [Related]
12. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
13. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
14. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model.
Pourtier-Manzanedo A; Vercamer C; Van Belle E; Mattot V; Mouquet F; Vandenbunder B
Oncogene; 2003 Mar; 22(12):1795-806. PubMed ID: 12660815
[TBL] [Abstract][Full Text] [Related]
15. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements.
Hegen A; Koidl S; Weindel K; Marmé D; Augustin HG; Fiedler U
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1803-9. PubMed ID: 15284088
[TBL] [Abstract][Full Text] [Related]
16. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
Wang J; Shannon MF; Young IG
Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
Martin TA; Mansel R; Jiang WG
Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
[TBL] [Abstract][Full Text] [Related]
18. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
[TBL] [Abstract][Full Text] [Related]
19. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
Rodrigo I; Cato AC; Cano A
Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
[TBL] [Abstract][Full Text] [Related]
20. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
